# Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation

> **NCT01841632** · PHASE1 · TERMINATED · sponsor: **Prof. Dr. Marc-H. Dahlke, Ph. D.** · enrollment: 3 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** MultiStem

## Key facts

- **NCT ID:** NCT01841632
- **Lead sponsor:** Prof. Dr. Marc-H. Dahlke, Ph. D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2018-08-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01841632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01841632, "Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01841632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*